SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 102.33 |
| Enterprise Value ($M) | 80.14 |
| Book Value ($M) | 59.62 |
| Book Value / Share | 0.35 |
| Price / Book | 1.72 |
| NCAV ($M) | 24.43 |
| NCAV / Share | 0.14 |
| Price / NCAV | 4.19 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.12 |
| Return on Assets (ROA) | -0.11 |
| Return on Equity (ROE) | -0.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.80 |
| Current Ratio | 4.89 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 142.97 |
| Assets | 178.16 |
| Liabilities | 118.54 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | |||
| 13G | BlackRock, Inc. | 6.70 | 0.00 | |
| 13G | Acorn Bioventures, L.p. | 9.99 | ||
| 13G/A | Lincoln Park Capital Fund, LLC | 0.95 | -11.60 | |
| 13G/A | Orbimed Advisors Llc | 6.70 | 11.29 | |
| 13G/A | Bain Capital Life Sciences Fund, L.P. | 9.99 | 38.63 | |
| 13G/A | Millennium Management Llc | 1.00 | -79.87 | |
| 13G/A | Empery Asset Management, LP | 2.65 | -26.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 616,405 | 2,074,418 | 29.71 | |
| 942,791 | 2,918,605 | 32.30 | |
| 5,775,588 | 15,671,202 | 36.85 | |
| 7,512,653 | 20,290,917 | 37.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| WINT – Windtree Therapeutics, Inc. | XBIO – Xenetic Biosciences, Inc. |
| XCUR – Exicure, Inc. | ZURA – Zura Bio Limited |
Financial data and stock pages provided by
Fintel.io